Khalili H - Search Results

1

Antibiotic use during the first 6 months of COVID-19 pandemic in Iran: A large-scale multi-centre study.

Salehi M, Khalili H, Seifi A, Davoudi H, Darazam IA, Jahangard-Rafsanjani Z, Mohammadnejad E, Heydari B, Siahkaly SJM, Tabarsi P, Kalantari S, Menshadi SAD, Babamahmoodi F, Khorvash F, Davarpanah MA, Soltani R, Yaghoobi MH, Anari SAM, Khodadadi J, Aliramezani A, Hantooshzadeh S, Naderi HR, Hajiabdolbaghi M, Elyasi S, Firouzabadi D, Kasgari HA, Roshanzamiri S, Ebrahimpour S. Salehi M, et al. Among authors: khalili h. J Clin Pharm Ther. 2022 Dec;47(12):2140-2151. doi: 10.1111/jcpt.13761. Epub 2022 Aug 21. J Clin Pharm Ther. 2022. PMID: 36054303 Free PMC article.

2

Is there any difference between acetylator phenotypes in tuberculosis patients and healthy subjects?

Khalili H, Dashti-Khavidaki S, Amini M, Mahjub R, Hajiabdolbaghi M. Khalili H, et al. Eur J Clin Pharmacol. 2010 Mar;66(3):261-7. doi: 10.1007/s00228-009-0745-1. Eur J Clin Pharmacol. 2010. PMID: 20187288

3

Association of N-acetyltransferase-2 genotypes and anti-tuberculosis induced liver injury; first case-controlled study from Iran.

Khalili H, Fouladdel S, Sistanizad M, Hajiabdolbaghi M, Azizi E. Khalili H, et al. Curr Drug Saf. 2011 Feb 1;6(1):17-22. doi: 10.2174/157488611794479946. Curr Drug Saf. 2011. PMID: 21047300

4

Adherence to empiric antibiotic therapy guideline in a referral teaching hospital, Tehran, Iran.

Khalili H, Elyasi S, Hatamkhani S, Dashti-Khavidaki S. Khalili H, et al. Acta Med Iran. 2012;50(1):47-52. Acta Med Iran. 2012. PMID: 22267379 Free article.

5

Errors in fluid therapy in medical wards.

Mousavi M, Khalili H, Dashti-Khavidaki S. Mousavi M, et al. Among authors: khalili h. Int J Clin Pharm. 2012 Apr;34(2):374-81. doi: 10.1007/s11096-012-9620-8. Epub 2012 Mar 6. Int J Clin Pharm. 2012. PMID: 22392405

6

Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.

Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A. Elyasi S, et al. Among authors: khalili h. Eur J Clin Pharmacol. 2012 Sep;68(9):1243-55. doi: 10.1007/s00228-012-1259-9. Epub 2012 Mar 13. Eur J Clin Pharmacol. 2012. PMID: 22411630 Review.

7

Adherence to Antiretroviral Therapy Among Iranian HIV/AIDS Patients.

Khalili H, Rohani R, Seyedalinaghi S, Hajiabdolbaghi M, Dashti-Khavidaki S, Talasaz AH. Khalili H, et al. Curr Clin Pharmacol. 2012 May;7(2):111-115. doi: 10.2174/157488412800228910. Curr Clin Pharmacol. 2012. PMID: 22432842

8

Efavirenz severe hypersensitivity reaction: case report and rapid desensitization protocol development.

Khalili H, Farasatinasab M, Hajiabdolbaghi M. Khalili H, et al. Ann Pharmacother. 2012 May;46(5):e12. doi: 10.1345/aph.1Q773. Epub 2012 Apr 24. Ann Pharmacother. 2012. PMID: 22535841

9

Antimicrobial resistance pattern of gram-negative bacteria of nosocomial origin at a teaching hospital in the Islamic Republic of Iran.

Khalili H, Soltani R, Safhami S, Dashti-Khavidaki S, Alijani B. Khalili H, et al. East Mediterr Health J. 2012 Feb;18(2):172-7. doi: 10.26719/2012.18.2.172. East Mediterr Health J. 2012. PMID: 22571095 Free article.

10

Nosocomial Gram-positive antimicrobial susceptibility pattern at a referral teaching hospital in Tehran, Iran.

Soltani R, Khalili H, Abdollahi A, Rasoolinejad M, Dashti-Khavidaki S. Soltani R, et al. Among authors: khalili h. Future Microbiol. 2012 Jul;7(7):903-10. doi: 10.2217/fmb.12.51. Future Microbiol. 2012. PMID: 22827310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

622 results

Search Page